Prevalence of vitamin D deficiency in sickle cell disease: a systematic review

Vikki G Nolan, Kerri A Nottage, Elliott W Cole, Jane S Hankins, James G Gurney, Vikki G Nolan, Kerri A Nottage, Elliott W Cole, Jane S Hankins, James G Gurney

Abstract

Vitamin D deficiency has emerged as a public health focus in recent years and patients with sickle cell disease (SCD) reportedly have a high prevalence of the condition. Our objectives were to summarize definitions of vitamin D deficiency and insufficiency used in the literature, and to determine the prevalence and magnitude of each in patients with SCD through a systematic review conducted according to PRISMA guidelines. From a PubMed search, 34 potential articles were identified and 15 met eligibility criteria for inclusion. Definitions of deficiency and insufficiency varied greatly across studies making direct comparisons difficult. This review provides evidence to suggest that suboptimal vitamin D levels are highly prevalent among those with SCD, far more so than in comparable non-SCD patients or matched control populations. Defining deficiency as vitamin D < 20 ng/mL, prevalence estimates in SCD populations range from 56.4% to 96.4%. When compared with results from the population-based National Health and Nutrition Examination Survey, however, the general African American population appeared to have a similarly high prevalence of vitamin D deficiency. African American patients with and without SCD were both substantially higher than that of Caucasians. What remains to be determined is whether there are adverse health effects for patients with SCD because of concurrent vitamin D deficiency.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. PRISMA Flow Diagram.
Fig 1. PRISMA Flow Diagram.
Flowchart of publications included in this systematic review.

References

    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266–281.
    1. Buison AM, Kawchak DA, Schall J, Ohene-Frempong K, Stallings VA, Zemel BS. Low vitamin D status in children with sickle cell disease. J Pediatr. 2004; 145: 622–627.
    1. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009; 20: 1807–1820. 10.1007/s00198-009-0954-6
    1. Rovner AJ, O'Brien KO. Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med. 2008; 162: 513–519. 10.1001/archpedi.162.6.513
    1. Sadat-Ali M, Al-Elq A, Al-Turki H, Sultan O, Al-Ali A, AlMulhim F. Vitamin D level among patients with sickle cell anemia and its influence on bone. Am J Hematol. 2011; 86: 506–507. 10.1002/ajh.22010
    1. Brinker MR, Thomas KA, Meyers SJ, Texada T, Humbert JR, Cook SD, et al. Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop Belle Mead NJ. 1998; 27: 43–49.
    1. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. The Cochrane Library. 2011
    1. Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012; 5: 819–829. 10.1161/CIRCOUTCOMES.112.967604
    1. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117: 503–511. 10.1161/CIRCULATIONAHA.107.706127
    1. Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009; 179:765–771. 10.1164/rccm.200808-1361OC
    1. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010; 126: 52–58.e55. 10.1016/j.jaci.2010.03.043
    1. Gupta A, Sjoukes A, Richards D, Banya W, Hawrylowicz C, Bush A, et al. Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med. 2011; 184: 1342–1349. 10.1164/rccm.201107-1239OC
    1. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007; 71: 31–38.
    1. Glover TL, Goodin BR, Horgas AL, Kindler LL, King CD, Sibille KT, et al. Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis. Arthritis Rheum. 2012; 64: 3926–3935. 10.1002/art.37687
    1. Kim TH, Lee BH, Lee HM, Lee SH, Park JO, Kim HS, et al. Prevalence of vitamin D deficiency in patients with lumbar spinal stenosis and its relationship with pain. Pain Physician. 2013; 16: 165–176.
    1. McBeth J, Pye SR, O'Neill TW, Macfarlane GJ, Tajar A, Bartfai G, et al. Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann Rheum Dis. 2010; 69: 1448–1452. 10.1136/ard.2009.116053
    1. Osunkwo I, Hodgman EI, Cherry K, Dampier C, Eckman J, Ziegler TR, et al. Vitamin D deficiency and chronic pain in sickle cell disease. Br J Haematol. 2011; 153.
    1. Osunkwo I. Complete Resolution of Sickle Cell Chronic Pain With High Dose Vitamin D Therapy: A Case Report and Review of the Literature. Journal of Pediatric Hematology Oncology. 2011; 33.
    1. Osunkwo I, Ziegler TR, Alvarez J, McCracken C, Cherry K, Osunkwo CE, et al. High dose vitamin D therapy for chronic pain in children and adolescents with. Br J Haematol. 2012; 159: 211–215. 10.1111/bjh.12019
    1. Ballas SK, Darbari DS. Neuropathy, neuropathic pain, and sickle cell disease. Am J Hematol. 2013; 88: 927–929. 10.1002/ajh.23575
    1. Boyd JH, Moinuddin A, Strunk RC, DeBaun MR. Asthma and acute chest in sickle-cell disease. Pediatr Pulmonol 2004; 38: 229–232.
    1. Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012; 59: 1123–1133. 10.1016/j.jacc.2011.10.900
    1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010; 376: 2018–2031. 10.1016/S0140-6736(10)61029-X
    1. Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999; 340: 1021–1030.
    1. Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, et al. Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults. Bone. 2013; 52: 206–211. 10.1016/j.bone.2012.10.005
    1. Garrido C, Cela E, Belendez C, Mata C, Huerta J. Status of vitamin D in children with sickle cell disease living in Madrid, Spain. Eur J Pediatr. 2012; 171: 1793–1798. 10.1007/s00431-012-1817-2
    1. Ibidapo MO, Akinyanju OO. Acute sickle cell syndromes in Nigerian adults. Clin Lab Haematol. 2000; 22: 151–155.
    1. NHS Antenal and Newborn Screening Programmes. Sickle cell disease in childhood, standards and guidelines for clinical care. London, United Kingdom. 2007
    1. Julka RN, Aduli F, Lamps LW, Olden KW. Ischemic duodenal ulcer, an unusual presentation of sickle cell disease. J Natl Med Assoc. 2008; 100: 339–341.
    1. Phebus CK, Maciak BJ, Gloninger MF, Paul HS. Zinc status of children with sickle cell disease: relationship to poor growth. Am J Hematol. 1988; 29: 67–73.
    1. Barden EM, Zemel BS, Kawchak DA, Goran MI, Ohene-Frempong K, Stallings VA. Total and resting energy expenditure in children with sickle cell disease. J Pediatr. 2000; 136: 73–79.
    1. Gray NT, Bartlett JM, Kolasa KM, Marcuard SP, Holbrook CT, Horner RD. Nutritional status and dietary intake of children with sickle cell anemia. Am J Pediatr Hematol Oncol. 1992; 14: 57–61.
    1. Kopp-Hoolihan LE, van Loan MD, Mentzer WC, Heyman MB. Elevated resting energy expenditure in adolescents with sickle cell anemia. J Am Diet Assoc. 1999; 99: 195–199.
    1. O'Connor MY, Thoreson CK, Ramsey NL, Ricks M, Sumner AE. The uncertain significance of low vitamin D levels in African descent populations: a review of the bone and cardiometabolic literature. Prog Cardiovasc Dis. 2013; 56: 261–269. 10.1016/j.pcad.2013.10.015
    1. Odonkor PO. Metabolic and endocrine basis of the growth retardation in sickle cell disease. Bull Eur Physiopathol Respir. 1983; 19: 357–359.
    1. Reid M. Nutrition and sickle cell disease. C R Biol. 2013; 336: 159–163. 10.1016/j.crvi.2012.09.007
    1. Salman EK, Haymond MW, Bayne E, Sager BK, Wiisanen A, Pitel P, et al. Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res. 1996; 40: 34–40.
    1. Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR. Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr. 1993; 57: 32–34.
    1. Singhal A, Parker S, Linsell L, Serjeant G. Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. Am J Clin Nutr. 2002; 75: 1093–1097.
    1. Jarvis JK, Miller GD. Overcoming the barrier of lactose intolerance to reduce health disparities. J Natl Med Assoc. 2002; 94: 55–66.
    1. Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013; 66: 620–622. 10.1136/jclinpath-2012-201301
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6: e1000097 10.1371/journal.pmed.1000097
    1. Miller RG, Segal JB, Ashar BH, Leung S, Ahmed S, Siddique S, et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol. 2006; 81: 236–241.
    1. Goodman BM 3rd, Artz N, Radford B, Chen IA. Prevalence of vitamin D deficiency in adults with sickle cell disease. J Natl Med Assoc. 2010; 102: 332–335.
    1. Jackson TC, Krauss MJ, Debaun MR, Strunk RC, Arbelaez AM. Vitamin D deficiency and comorbidities in children with sickle cell anemia. Pediatr Hematol Oncol. 2012; 29: 261–266. 10.3109/08880018.2012.661034
    1. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006; 47: 901–906.
    1. Osunkwo I, Hodgman EI, Cherry K, Dampier C, Eckman J, Ziegler TR, et al. Vitamin D deficiency and chronic pain in sickle cell disease. Br J Haematol. 2011; 153: 538–540. 10.1111/j.1365-2141.2010.08458.x
    1. Osunkwo I, Ziegler TR, Alvarez J, McCracken C, Cherry K, Osunkwo CE, et al. High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study. Br J Haematol. 2012; 159: 211–215. 10.1111/bjh.12019
    1. Rovner AJ, Stallings VA, Kawchak DA, Schall JI, Ohene-Frempong K, Zemel BS. High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc. 2008; 108: 1512–1516. 10.1016/j.jada.2008.06.433
    1. Ozen S, Unal S, Ercetin N, Tasdelen B. Frequency and risk factors of endocrine complications in Turkish children and adolescents with sickle cell anemia. Turk J Haematol. 2013; 30: 25–31. 10.4274/tjh.2012.0001
    1. van der Dijs FP, van der Klis FR, Muskiet FD, Muskiet FA. Serum calcium and vitamin D status of patients with sickle cell disease in Curacao. Ann Clin Biochem. 1997; 34 Pt 2: 170–172.
    1. Mohammed S, Addae S, Suleiman S, Adzaku F, Annobil S, Kaddoumi O, et al. Serum calcium, parathyroid hormone, and vitamin D status in children and young adults with sickle cell disease. Ann Clin Biochem. 1993; 30 Pt 1: 45–51.
    1. Sadat-Ali M, Al-Elq A, Al-Turki H, Sultan O, Al-Ali A, AlMulhim F. Vitamin D level among patients with sickle cell anemia and its influence on bone mass. Am J Hematol. 2011; 86: 506–507. 10.1002/ajh.22010
    1. Chapelon E, Garabedian M, Brousse V, Souberbielle JC, Bresson JL, de Montalembert M. Osteopenia and vitamin D deficiency in children with sickle cell disease. Eur J Haematol. 2009; 83: 572–578. 10.1111/j.1600-0609.2009.01333.x
    1. Sedrani SH, Elidrissy AW, El Arabi KM. Sunlight and vitamin D status in normal Saudi subjects. Am J Clin Nutr. 1983; 38: 129–132.
    1. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med. 2009; 169: 626–632. 10.1001/archinternmed.2008.604
    1. Gutierrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011; 22: 1745–1753. 10.1007/s00198-010-1383-2
    1. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest. 1985; 76: 470–473.
    1. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D endocrine system in obese subjects. J Clin Invest. 1985. 76: 370–373.
    1. Rosenstreich SJ, Rich C, Volwiler W. Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest. 1971; 50: 679–687.
    1. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72: 690–693.
    1. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tissue Int. 2002; 70:70–73.
    1. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369: 1991–2000. 10.1056/NEJMoa1306357
    1. Powe CE, Karumanchi SA, Thadhani R. Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med. 2014; 370: 880–881. 10.1056/NEJMc1315850
    1. Wright NC, Chen L, Niu J, Neogi T, Javiad K, Nevitt MA, et al. Defining physiologically "normal" vitamin D in African Americans. Osteoporos Int. 2012; 23: 2283–2291. 10.1007/s00198-011-1877-6
    1. Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr. 2006; 84: 602–609.
    1. Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006; 17: 2228–2235.
    1. Sklar AH, Campbell H, Caruana RJ, Lightfoot BO, Gaier JG, Milner P. A population study of renal function in sickle cell anemia. Int J Artif Organs. 1990; 13: 231–236.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera